Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to determine the safety (phase II), then efficacy (phase III) of baricitinib plus standard of care (SOC) as compared to SOC alone for the treatment of hospital-acqui...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nantes University Hospital
NCT04153682 · Hospital-acquired Pneumonia
NCT05483309 · Hospital-acquired Pneumonia
NCT05785442 · Community-acquired Pneumonia, Hospital-acquired Pneumonia
NCT05624684 · Community-acquired Pneumonia, Hospital-acquired Pneumonia, and more
NCT04700202 · Ventilator-associated Pneumonia, Hospital-acquired Pneumonia
St-Luc Clinics
Brussels
Ghent University Hospital
Ghent
Groupe Jolimont
Haine-Saint-Paul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions